Report Library
All ReportsDatamonitor Healthcare Strategy: Orphan Drug Access and Pricing in Emerging Markets
January 12, 2018
This analysis covers the four major emerging regions of the Middle East and Africa, Latin America, Eastern Europe, and Asia-Pacific. Within
these regions, relatively wealthier markets with a proven marketplace for orphan medicines have been prioritized. The topic focus is on rare-
disease policy, access, and pricing, as well as the stakeholder landscape for low-prevalence disorders and orphan drugs. For the purposes of
this analysis, local definitions for rare disease were used where available, as well as conventional definitions of both “ultra-orphan” disorders
and rare tumor types.
This Datamonitor Healthcare report contains a Strategy module.
This Datamonitor Healthcare report contains a Strategy module.
Disease Group Covered: | Not Specified |